source
- Servier acquires Edgewise's muscular dystrophy assets for $1.55 billionServier announced it will purchase the muscular dystrophy business from Edgewise Therapeutics. The deal involves an upfront payment of $1.55 billion, giving the French company rights to Edgewise's…
- Servier to acquire Edgewise Therapeutics' muscular dystrophy program for up to $2.65 billionFrench pharma group Servier announced it will purchase Edgewise Therapeutics' muscular dystrophy business. The transaction is valued at up to $2.65 billion, comprising a $1.55 billion upfront cash…